March 20, 2024 · Form 4 insider transaction
Pizzuti Dana sold 10,000 shares of Crinetics Pharmaceuticals, Inc. at $43.28 per share, a transaction worth $432.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.28 per share. The range of sales prices on the transaction date was $42.70 to $43.77 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.